Nuzenio

Discuss Topline Phase

Discuss Topline Phase news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:42:06 GMT NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 13:23:29 GMT NeOnc Technologies Holdings to Host Investor Call on Phase 2a Topline Results for NEO100-01 Trial - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMT Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:30:00 GMT Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:19 GMT Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - Business WireBusiness Wire · Sun, 09 Aug 2026 21:00:00 GMT Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 13:42:06 GMTNeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma - Yahoo Finance

Mon, 10 Aug 2026 13:23:29 GMTNeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout - The Manila Times

Mon, 10 Aug 2026 12:47:00 GMTNeOnc Technologies Holdings to Host Investor Call on Phase 2a Topline Results for NEO100-01 Trial - Quiver Quantitative

Mon, 10 Aug 2026 11:30:00 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business Wire

Mon, 10 Aug 2026 11:19:19 GMTTenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - The Manila Times

Sun, 09 Aug 2026 21:00:00 GMTSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - Business Wire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Phase8 live mentions Topline Results7 live mentions The Manila Times5 live mentions SANRECO Trial4 live mentions Divesiran4 live mentions Trial3 live mentions Polycythemia Vera3 live mentions Host Investor Conference2 live mentions Call2 live mentions Results2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Discuss Topline Phase.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.